IntraBio is on a roll with its expansion plans for chemically altered amino acid, Aqneursa. | IntraBio's streak of success in the rare neurological category continues, as the drugmaker racks up a ...

Friedreich’s ataxia patients met with staff from Tallaght Hospital last week who explained the limitations in the current ...

Ataxia means the loss of coordination of body movements. Acute cerebellar ataxia is a disorder in children that causes a sudden loss of coordination. It is relatively prevalent in children, especially ...

Lexeo Therapeutics, Inc. ( LXEO) is strengthening its position in Friedreich ataxia through the planned acquisition of Mantle Therapeutics and the launch of patients living with the rare genetic ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, will provide Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage company ...

The medication, which has the brand name Skyclarys, has been shown to offer a 54% chance of slowing the progression of the ...

Ataxia is a form of movement disorder. There is loss of balance and physical co-ordination leading to difficulty in walking normally. The Cerebellum of the brain is normally responsible for ...

The FDA has approved Aqneursa (levacetylleucine) for ataxia in adult and pediatric patients with ataxia-telangiectasia weighing at least 15 kg.

Cerebellar rhythm loss due to climbing fiber regression is a shared pathophysiology of motor deficits across cerebellar ataxias. Cerebellar ataxias are a group of genetic and non-genetic disorders ...

Ataxia is the defect in normal movements like walking, speaking, eating swallowing etc. It is caused most commonly by damage to the brain stem or cerebellum that regulates movements. There are over 50 ...

Difficulty balancing or an inability to do so can be caused by any number of factors. Head injuries, migraines, alcohol use, ear infections and medications can all affect your musculoskeletal system ...